Find an expert

A/Professor Tripathi is a Vascular and Endovascular Surgeon in Brisbane and Wide Bay areas. He is an Adjunct Professor at University of Sunshine Coast and Associate Professor at Faculty of Medicine and School of Biomedical Sciences at University of Queensland.

He is a Fellow of the Royal Australasian College of Surgeons in Vascular Surgery, a senior member of Royal Australasian College of Surgeons' Academy of Surgical Educators and of the Section of Academic Surgery.

He is a Distinguished Fellow of Society for Vascular Surgery (USA) and of American Venous Forum (AVF). He was conferred with an Honorary Membership of European Venous Forum for his outstanding contribution to art and science of venous surgery in 2018. He is also the 2017 recipient of Asterios Katsamouris Lecture by the European Society for Cardiovascular Surgery. He was inducted into Sigma Xi Honors Research Society in 2017. He frequently lectures to professional societies and leading vascular and Endovascular conferences throughout the world.

Dr Tripathi’s academic recognition includes distinguished visiting Professorships to Division of Vascular and Endovascular Surgery of Stanford University, Palo Alto, California, USA and Mayo Clinic and Mayo School of Medicine, Rochester, USA, University of Saint Louis, St Louis, USA, Karolinska University Hospitals, Stockholm, Sweden, University of British Columbia, Vancouver, Canada and University of Lisbon, Portugal.

Dr. Tripathi is an associate editor of Journal of Endovascular Therapy and sits on the editorial boards of Journal of Vascular Surgery, Journal of Cardiovascular Surgery, Vascular, Phlebology, Aorta, International Angiology, Asian Journal of Surgery, Endovascular Today and Vascular Disease Management. He is a distinguished reviewer for European Journal of Vascular and Endovascular Surgery and Journal of Vascular Interventional Radiology.

Peter obtained his medical degree at the Comenius University, Bratislava, Slovakia. He completed his paediatric nephrology fellowship and worked as a paediatric nephrologist at the British Columbia Children’s Hospital in Vancouver, Canada. Peter moved to Brisbane in 2010 and worked as a staff nephrologist at both Royal Children's Hospital and Mater Children's Hospital. He became the Director of Nephrology at Lady Cilento Children's Hospital in November 2014. Peter is currently the Service Group Director of Endocrinology and Nephrology at Queensland Children's Hospital. He is the Director of Queensland Child and Adolescent Renal Service, a state-wide service providing the nephrology care for children with kidney disease, including dialysis, kidney transplant and apheresis service.

Peter also holds a Master of Science degree in Experimental Medicine from the University of British Columbia, Canada. He is an Associate Professor at the School of Medicine, the University of Queensland.

Research Interests

Congenital anomalies of the kidneys and urinary tract, obstructive nephropathy, biomarkers of chronic kidney disease, renal tumours associated with tuberous sclerosis.

Dr. Stewart Trost is a Professor in the School of Human Movement Studies Department at The University of Queensland. Trost received his PhD in Exercise Physiology from the University of South Carolina, Colombia SC, USA. Trost leads the Children’s Physical Activity Research Group (CPARG) at the QLD Centre of Children’s Health Research. CPARG is dedicated to expanding the body of knowledge on physical activity and its promotion in children and adolescents. An overarching aim of CPARG is to enhance the health of young people by generating the knowledge needed to design and implement effective programs to increase physical activity in children with typical development and those with chronic and complex health conditions. His research interests include device-based assessment of physical activity and sedentary behavior, early life prevention of childhood obesity and chronic disease, therapeutic exercise programs for children with chronic health conditions, and the relationships between physical activity and other health behaviors.

Mike is a Research Fellow in Psychiatric Epidemiology and Evidence Synthesis with the Queensland Centre for Mental Health Research. Currently Mike works on large, administravely linked datasets and works with statistics in clinical trials. Mike's background was firstly in the UK military, with a subsequent career in the fitness industry - being named the global top fitness instructor in 2015, and European top fitness educator in 2018. Mike then continued his exercise career through academia, completing his PhD in Sport and Exercise Sciences in 2022, and working with the Cambridge Centre for Sport and Exercise Sciences, and the Cambridge Vision and Eye Research Institute post-PhD. Mike's currnet research interests span the umbrella of mental health and statistics - in particular phsyical acitivty and sendentary behaviour in people with severe mental illness, intergenerational child maltreatment, and statistical considerations in complex clinical trails.

Matt is completing his PhD in supercritical ethylene injection into supersonic crossflow where he investigated the mixing characteristics of this high pressure, high temperature fueling regime. His current research interests are in supersonic combustion studies, hypersonic boundary layer transition, and advancing the optical diagnostic tools used in hypersonic experimentation.

After ​Dr. Tryggestad obtained his Bachelor's of Science in Agricultural Sciences from the University of Western Illinois, he joined the Plant Performance Laboratory led by Dr. Jitka Kochanek. While studying under Dr. Kochanek, Dr. Tryggestad gained his PhD through his thesis titled, "The optimisation of novel plant promoting compounds and their delivery methods", from The University of Queensland in 2022. Shortly after completion of his PhD, he and Dr. Kochanek partnered with Bulugudu Limited to develop a novel sustainable material for the purposes of increasing chemical delivery effectiveness. Currently, The Plant Performance Laboratory and Bulugudu continue their partnership through the further development and commercilisation of the novel technology platform material within the Advanced Spinifex Biofutures Centre led by Dr. Jan Lauko within the Australian Institute for Bioengineering and Nanotechnology.

Dr. Wei-An (Vivien) Tsai graduated with a Bachelor of Science in the Department of Plant Pathology and Microbiology, as well as a Master of Science from the Institute of Plant Biology at National Taiwan University in Taiwan. In 2023, she completed her doctoral studies at the Queensland Alliance for Agriculture and Food Innovation (QAAFI), The University of Queensland. Her research during PhD studies aimed to uncover the involvement of small RNA in plant-capsicum chlorosis virus pathosystem under climate change scenarios of elevated temperatures. Additionally, she explored the potential of using RNA-based techniques for managing CaCV. Before joining QAAFI, Wei-An worked at the Hualien District Agricultural Research and Extension Station, Ministry of Agriculture in Taiwan. During this period, her research interests centred around plant-induced resistance to viruses and the selection and fermentation of antagonistic bacteria. Post-PhD, Wei-An joined the Mitter group as a postdoctoral researcher for the Australia-India Strategic Research Fund project. Her current focus lies in topical applications of dsRNA or other RNA-based techniques for targeting whitefly and whitefly-transmitted viruses including tomato yellow leaf curl virus.

Dr Ben Tscharke is an analytical chemist with a keen interest in quantifying analytes in environmental samples. Ben is currently a Senior Research Fellow at the University of Queensland research institute, Queensland Alliance for Environmental Health Sciences (QAEHS), joining in February 2017 after graduating his PhD from the University of South Australia the previous year. His key focus at QAEHS involves the wastewater based epidemiological approach to determine community consumption and exposure to a range of illicit drugs, pharmaceuticals and personal care products. He leads the Australian Criminal Intelligence Commission's National Wastewater Drug Monitoring program at UQ, which collaborates with the University of South Australia (https://www.acic.gov.au/publications/intelligence-products/national-wastewater-drug-monitoring-program-report).

Elinor Tsen is a Postdoctoral Research Fellow at the School of Electrical Engineering and Computer Science.

Elinor's research interests relate to the adoption and development of mature cyber security and resilience practices within organisations.

Professor Kylie Tucker leads a positive research environment, where exceptional basic science and clinical researchers come together to advance knowledge about muscles and movement control. Her work has transformed our understanding of how pain impacts movement; showcased methods for estimating muscle forces; and advanced the assessment of childhood movement control and adolescent skeletal maturity. Recently, Kylie has drawn on her fundamental science knowledge to propose a shift in our understanding of the potential drivers of scoliosis progression. Approximately one child in every Australian classroom, and 3-7% world-wide, will develop adolescent idiopathic scoliosis. There is no known cause, nor strong evidence to determine when or where to target non-invasive treatment. Each year in Queensland >200 adolescents have up to 12 vertebrae fused as conservative treatment has not stopped their curve progression. Her group have identified unique, targetable muscle features, that can be non-invasively detected early in curve progression.

In parallel to her research, Kylie teaches about muscles and movement control across 10 UQ programs, where class size ranges from 70-1400 students. Within the School of Biomedical Science she was the Deputy Director Teaching and Learning (2018-20), the inaugural chair of the people centred, REMEDE committee (2021-23); and Director of Teaching and Learning (2024-3/25). Kylie co-facilitates UQ’s flagship Career Progression for Women program (2024- ), and intentionally fosters a supportive academic culture, empowering academics in their pursuit of excellence, across all her roles. She is the current (2024-26) President of the International Society of Electrophysiology and Kinesiology (ISEK); a global organization composed of 375 members in health-related and basic science fields with a common desire to study human movement and the neuromuscular system. Kylie has contributed to the leadership of this society since 2018.

Karen Tuesley is an early career researcher and Lecturer in epidemiology at the School of Public Health, University of Queensland. Karen’s research focuses on women’s health and cancer epidemiology using large longitudinal datasets. Her PhD research used large-scale data to explore the associations between the use of chronic disease medications and the risk of ovarian cancer. She also researches long-term health outcomes for women after gynaecological surgery. Karen works with large observational studies with longitudinal data and is experienced with different analytic techniques and methods including emulated trials and Mendelian randomisation.

I am the lead of the Effective and Efficient Healthcare program at the Centre for the Business and Economics of Health at The University of Queensland. I also lead Health Technology Assessment for the Centre, which involves evaluating submissions made to the Australian Government to reimburse new medicines and medical devices through the Pharmaceutical benefits Scheme (PBS) and the Medicare Benefits Schedule (MBS). My research is focused on the economic evaluation of health interventions to inform decision making and promote value-based health care. I have pioneered the application of Value of Information (Research) analysis to enhance the efficiency of clinical trials and maximise the return on investment from medical research.

I have extensive experience working with key stakeholders including consumers, clinicians, decision makers and researchers. I am chief investigator on over $45 million Category 1 grants from the NHMRC, MRFF and ARC. In addition, I lead several projects for the Department of Health and other peak organisations.

I chair the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)-Oncology GroupI, and I am the past chair of the Clinical Oncology Society of Australia's (COSA)-Epidemiology Group and the Australian Clinical Trials Alliance (ACTA)-Research Prioritisation Group. I am an Associate Editor for Value in Health, and an Editorial Board Member for Medical Decision Making and PharmacoEconomics-open journals.

John-Paul Tung is a Senior Research Fellow at Australian Red Cross Lifeblood (Lifeblood). He leads a program of research focused on the changes that occur in blood in between collection and transfusion, as well as how these changes might impact transfused patients. Particular focuses are on transfusion-related acute lung inujry (TRALI), transfusion-associated circulatory overload (TACO), and extracellular vesicles. He leads a research team of five Senior Research Assistants and three Research Assistants. He also supervises several PhD and Masters students. He holds an Honorary Senior Research Fellow position with the Faculty of Medicine at UQ. He also holds an adjunct Associate Professor position with the University of the Sunshine Coast and an adjunct Senior Lecturer position with QUT. He is also a former Secretary and Council Member of the International Society of Blood Transfusion's Young Professionals Council.

John-Paul completed a Bachelor of Science at UQ in 1999, after which he worked as a Scientist in nucleic acid testing in Brisbane, Melbourne and London. After returning to Brisbane, he commenced work as a Research Scientist with Lifeblood (formerly the Blood Service) in 2007. John-Paul then commenced a PhD with UQ and Prince Charles Hospital's Critical Care Research Group in 2008. His PhD, conferred in 2012, invovled the development of the first large animal model of TRALI using sheep, and resulted in several awards including best paper prizes from the International Society of Blood Transfusion and the Prince Charles Hospital as well as other awards from the Australian and New Zealand Society of Blood Transfusion and the British Blood Transfusion Society.

Dr. Kelvin Tuong is a Senior Research Fellow/Group Leader at the Ian Frazer Centre for Children’s Immunotherapy Research (IFCCIR), Child Health Research Centre. He is interested in single-cell analysis of immune cells and harnessing adaptive immune receptors for understanding immune cell development and function in health and in cancer.

Dr. Tuong was born and raised in Singapore and moved to Brisbane, Australia, after completing national service in Singapore and obtaining a Diploma in Biomedical Laboratory Technology (Ngee Ann Polytechnic).

Dr. Tuong was originally trained as a molecular cell biologist and gradually transitioned into bioinformatics during his post-doctoral training. He has been very prolific for an early career researcher, having published >70 articles since 2013, with nearly a third of them as first/co-first or last author and has a stellar track record of pushing out highly collaborative work in prestigious journals including Nature, Cell, Science, Nature Medicine, Nature Biotechnology J Exp Med etc. He has the rare combination of having excellent laboratory and bioinformatics skill sets which provide him a strong command of both fundamental immunology and computational approaches.

Dr. Tuong completed his undergraduate Bachelor's degree in Biomedical science with Class I Honours, followed by his PhD in macrophage cell biology and endocrinology at UQ (Prof. Jenny Stow lab and Emiritus Prof. George Muscat lab, IMB, UQ). He then went on to a post-doc position with Emiritus Prof. Ian Frazer (co-inventor of the Gardasil cervical cancer vaccine, UQ Frazer Institute, Translational Research Institute) where he worked on HPV immunology, cervical cancer and skin cancer. In his time in the Frazer lab, he developed an interest in bioinformatics analyses as a means to tackle and understanding immunology problems in health and disease. He then moved to the UK and joined Prof. Menna Clatworthy's lab at the University of Cambridge and Dr. Sarah Teichmann's lab at the Wellcome Trust Sanger Institute. He has focused his interests on single-cell analyses of tissue immune cells, including T and B cells and their specific receptors (TCR/BCR). He has developed bespoke bioinformatics software, including one tailored for single-cell B Cell Receptor sequencing analysis, Dandelion, which he used in one of the largest combined single-cell transcriptomic, surface proteomic and TCR/BCR sequencing dataset in the world, published in Nature Medicine, and more recently in Nature Biotechnology where we introduced a TCR-based pseudotime trajectory analysis method.

Dr. Tuong is now leading the Computational Immunology group at the IFCCIR and his lab is focused on investigating how pediatric immunity is perturbed during cancer at the cellular level and how this information can be used for creating novel warning systems for children with cancer. For potential students/post-docs/trainees interested in joining the team, please contact Dr. Tuong at z.tuong@uq.edu.au.

Karnaker's research interests are natural products, peptide-based drug discovery and development, formulation chemistry and non-viral gene delivery system. Karnaker co-inventor and developed a novel, bioresponsive disulphide-linker technology, which has been used for non-viral vectors, peptide-therapeutics for pain and cancer treatment. Karnaker is also keen interest for topical, mucosal drug delivery using a range of dendrimer, nano and microbubbles, lipid and polymer-based nanoparticle systems in conjugation with both biological and physical stimuli-responsiveness.

Karnaker received a PhD in Pharmaceutical Chemistry from The University Queensland under the supervision of Dr Harendra Parekh and Dr Defang Ouyang. Prior to PhD, he completed a Master degree in Pharmaceutical Analysis and Quality assurance (India). Also worked as analytical research and development chemist for one year in a Pharma company. Since 2016, he his working with Dr Parekh team on a range of Industry-funded research projects and his role involves from ideation, research plan, execution, product delivery to industry partners on major platforms such as peptide-based therapeutics, gene therapy and sol-gel technology.

Dr Michael Turner

Senior Lecturer in Accounting

Program Convenor, Bachelor of Advanced Business (Honours)

Dr Michael J. Turner is a Senior Lecturer in Accounting and Program Convenor for the Bachelor of Advanced Business (Honours) at The University of Queensland Business School. He holds a PhD in Accounting, a Bachelor of Business (First Class Honours) and a Graduate Certificate in Research Management.

Michael’s scholarship explains how decision‑oriented accounting information—and the management controls that create and communicate it—influence strategic, ethical and climate‑related choices across diverse organisations. He has authored 30‑plus peer‑reviewed articles (5 A★, 19 A ABDC; two FT 50), attracting 437 Scopus citations and an h‑index of 12 (as at June 2025). His projects have been funded by Chartered Accountants Australia & New Zealand, the German Research Foundation and the Australian Accounting Standards Board, and practitioner outlets such as Strategic Finance, HospitalityNet and the Council on Business & Society have featured his applied insights.

Research interests

• Strategic management accounting & analytics – capital budgeting, cost systems, competitor intelligence, AI pricing

• Corporate & climate‑related disclosure – economic consequences of ESG reporting

• Ethical decision‑making & governance – whistle‑blowing incentives, fraud deterrence

• Accounting education & technology – data‑analytics pedagogy with Python and R

A unifying question threads these streams together: How can accounting systems create and communicate information that drives smarter and more responsible business decisions?

Teaching & Program Leadership

Teaching. Michael coordinates management‑accounting courses that consistently receive outstanding teacher ratings in the mid‑ to high‑4s out of 5 . His Python‑ and R‑based cases have won international awards and are adopted worldwide.

Program leadership. As Program Convenor he applies a business‑analyst mindset—interrogating enrolment trends, assessment data and employer feedback—to steer evidence‑based improvements in curriculum design, assessment integrity and student experience.

Engagement & Service – Program Convenor spotlight

• Academic Program Review Lead (2023 – mid 2025).

  • Directed the first comprehensive review of UQ’s flagship Bachelor of Advanced Business (Honours) since its 2018 launch, coordinating faculty, students, alumni and external reviewers.

  • Delivered a data‑rich report mapping enrolment patterns, graduate outcomes and financial sustainability, and set a strategic agenda for work‑integrated learning, first‑year cohort building and program distinctiveness.

• Implementation Plan Leader (mid 2025 – mid 2028).

  • Leading cross‑disciplinary teams to design cohort‑specific advanced courses and new industry‑embedded learning experiences.

  • Monitoring key performance indicators—retention, satisfaction, graduate destinations—so that curricular changes translate into measurable impact.

• Continuous quality assurance.

  • Conducts targeted course audits to recalibrate marking guides, assessment weightings and learning resources, and mentors coordinators through change processes.